Table 2.
Characteristics of EWASs associated with glycaemic traits
Referencea | Population for DNA methylation analysis | Female/male | Design | Tissue | Method | Covariates included into analysis | Multiple-testing correctionb | Top findings | No. of CpGs included in replication studyc |
---|---|---|---|---|---|---|---|---|---|
Kriebel et al, 2016 [33] a | 1448 non-diabetic individuals (fasting glucose, 2-h glucose, HbA1c); 1440 non-diabetic individuals (fasting insulin, HOMA-IR); 617 non-diabetic individuals (2-h insulin) |
47.1% male | Cross-sectional | Blood | 450k | FDR | Age, sex, cell count (Houseman method), smoking, BMI | Total of 31 CpGs were found to be associated with phenotypic traits: 5 DMS associated with fasting glucose (including ABCG1, CPT1A), 1 with 2-h glucose, 8 with fasting insulin, 26 with HOMA-IR and none with HbA1c. Using a different model, adjustment for BMI resulted in ~30% reduction in effect size, suggesting BMI had a confounding effect | 3 for fasting glucose |
Kulkarni et al, 2015 [25] a | 850 pedigreed Mexican Americans (174 T2D patients) | 536/314 | Cross-sectional (case–control) |
Blood | 450k | Bonferroni | Age, sex, BMI, cell count (Jaffe method) | 51 CpGs were significantly associated with T2D, 19 with fasting glucose and 24 with HOMA-IR | 19 for fasting glucose |
Hidalgo et al, 2014 [34] | 544 healthy individuals in discovery stage, 293 in replication stage | 286/258 | Cross-sectional | Blood | 450k | Bonferroni | Age, sex, study site, 4 PC, insulin, glucose | 1 DMS associated with fasting insulin and HOMA-IR: ABCG1 (cg06500161); marginally significant site also in ABCG1 (cg1881899, p = 3.36 × 10−6), associated with HOMA-IR only. No DMS associated with fasting glucose | 0 (no information about insulin levels in Lifelines) |
Ronn et al, 2015 [35] a | 96 healthy male participants for discovery stage, 94 healthy female participants for validation stage, 2 separate EWASs performed | 96 male 94 female |
Cross-sectional association with age, BMI and HbA1c | Adipose tissue | 450k | FDR < 5%, q < 0.05 | Sex, family number; pedigree, age, BMI | 711 DMS associated with HbA1c were found in the male cohort with most significant negative correlation at ANKRD11 gene; 7 DMS associated with HbA1c were found in the female cohort, none of which were significantly associated with HbA1c level in the male cohort | 11 from male cohort |
aStudies included into replication study to provide CpGs, which passed strict Bonferroni correction threshold
bMultiple-testing threshold calculated originally by the authors of particular study
c0 in last column means zero CpG sites passed study-specific Bonferroni correction threshold
C, controls; DMS, differentially methylated sites; DMR, differentially methylated region; FDR, false discovery rate; HOMA-IR, homeostatic model assessment; NASH, non-alcoholic steatohepatitis; P, patients; PC, principal component; T2D, type 2 diabetes; 27k, Infinium HumanMethylation27 BeadChip; 450k, Infinium HumanMethylation450 BeadChip